Physical chemistry of polyglutamine: Intriguing tales of a monotonous sequence

Journal of Molecular Biology

Volumn 421, Issue 4-5, 2012, Pages 466-490

  Wetzel, Ronald ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

amyloid; huntingtin; intrinsically disordered protein; oligomer; polyglutamine

Indexed keywords

AMYLOID; ATAXIN 3; HEAT SHOCK PROTEIN 40; HEAT SHOCK PROTEIN 70; HUNTINGTIN; MONOMER; OLIGOMER; POLYGLUTAMINE; POLYMER; TRANSCRIPTION FACTOR;

ALPHA HELIX; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; BETA SHEET; CARBOXY TERMINAL SEQUENCE; CONFORMATION; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; EXON; HYDROGEN BOND; MOLECULAR DOCKING; MOLECULAR MODEL; NEUROTOXICITY; NONHUMAN; OLIGOMERIZATION; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN PROCESSING; PROTEIN STABILITY; PROTEIN STRUCTURE; REVIEW; THERMODYNAMICS;

EID: 84863990252     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2012.01.030     Document Type: Review

References (192)

1. Karlin S., and Burge C. Trinucleotide repeats and long homopeptides in genes and proteins associated with nervous system disease and development Proc. Natl Acad. Sci. USA 93 1996 1560 1565 (Pubitemid 26075164)
2. Margolis R.L., Abraham M.R., Gatchell S.B., Li S.H., Kidwai A.S., and Breschel T.S. cDNAs with long CAG trinucleotide repeats from human brain Hum. Genet. 100 1997 114 122 (Pubitemid 27309665)
3. Butland S.L., Devon R.S., Huang Y., Mead C.L., Meynert A.M., and Neal S.J. CAG-encoded polyglutamine length polymorphism in the human genome BMC Genomics 8 2007 18
4. Gerber H.P., Seipel K., Georgiev O., Hofferer M., Hug M., Rusconi S., and Schaffner W. Transcriptional activation modulated by homopolymeric glutamine and proline stretches Science 263 1994 808 811 (Pubitemid 24093208)
5. Wellner N., Belton P.S., and Tatham A.S. Fourier transform IR spectroscopic study of hydration-induced structure changes in the solid state of omega-gliadins Biochem. J. 319 1996 741 747 (Pubitemid 26386185)
6. Ridgley D.M., Ebanks K.C., and Barone J.R. Peptide mixtures can self-assemble into large amyloid fibers of varying size and morphology Biomacromolecules 12 2011 3770 3779
7. Zoghbi H.Y., and Orr H.T. Glutamine repeats and neurodegeneration Annu. Rev. Neurosci. 23 2000 217 247 (Pubitemid 30350043)
8. Bates G.P., and Benn C. The polyglutamine diseases G.P. Bates, P.S. Harper, L. Jones, Huntington's Disease 2002 Oxford University Press Oxford, UK 429 472
9. Wilburn B., Rudnicki D.D., Zhao J., Weitz T.M., Cheng Y., and Gu X.F. An antisense CAG repeat transcript at JPH3 locus mediates expanded polyglutamine protein toxicity in Huntington's disease-like 2 mice Neuron 70 2011 427 440
10. Zuccato C., Valenza M., and Cattaneo E. Molecular mechanisms and potential therapeutical targets in Huntington's disease Physiol. Rev. 90 2010 905 981
11. Biancalana V., Serville F., Pommier J., Julien J., Hanauer A., and Mandel J.L. Moderate instability of the trinucleotide repeat in spino bulbar muscular atrophy Hum. Mol. Genet. 1 1992 255 258
12. DiFiglia M., Sapp E., Chase K.O., Davies S.W., Bates G.P., Vonsattel J.P., and Aronin N. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain Science 277 1997 1990 1993 (Pubitemid 27449140)
13. Davies S.W., Turmaine M., Cozens B.A., DiFiglia M., Sharp A.H., and Ross C.A. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation Cell 90 1997 537 548 (Pubitemid 27347243)
14. Paulson H.L. Protein fate in neurodegenerative proteinopathies: polyglutamine diseases join the (mis)fold Am. J. Hum. Genet. 64 1999 339 345 (Pubitemid 129500515)
15. Neurath H., Greenstein J.P., Putnam F.W., and Erickson J.O. The chemistry of protein denaturation Chem. Rev. 34 1944 157 265
16. Colon W., and Kelly J.W. Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro Biochemistry 31 1992 8654 8660
17. Hurle M.R., Helms L.R., Li L., Chan W., and Wetzel R. A role for destabilizing amino acid replacements in light chain amyloidosis Proc. Natl Acad. Sci. USA 91 1994 5446 5450 (Pubitemid 24174344)
18. Wetzel R. Mutations and off-pathway aggregation Trends Biotechnol. 12 1994 193 198
19. Altschuler E.L., Hud N.V., Mazrimas J.A., and Rupp B. Random coil conformation for extended polyglutamine stretches in aqueous soluble monomeric peptides J. Pept. Res. 50 1997 73 75 (Pubitemid 27345451)
20. Chen S., Berthelier V., Yang W., and Wetzel R. Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity J. Mol. Biol. 311 2001 173 182 (Pubitemid 32735322)
21. Masino L., Kelly G., Leonard K., Trottier Y., and Pastore A. Solution structure of polyglutamine tracts in GST-polyglutamine fusion proteins FEBS Lett. 513 2002 267 272 (Pubitemid 34251276)
22. Klein F.A., Pastore A., Masino L., Zeder-Lutz G., Nierengarten H., and Oulad-Abdelghani M. Pathogenic and non-pathogenic polyglutamine tracts have similar structural properties: towards a length-dependent toxicity gradient J. Mol. Biol. 371 2007 235 244 (Pubitemid 47044840)
23. Chen S., Ferrone F., and Wetzel R. Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation Proc. Natl Acad. Sci. USA 99 2002 11884 11889 (Pubitemid 34994493)
24. Kim M.W., Chelliah Y., Kim S.W., Otwinowski Z., and Bezprozvanny I. Secondary structure of Huntingtin amino-terminal region Structure 17 2009 1205 1212
25. Bhattacharyya A., Thakur A.K., Chellgren V.M., Thiagarajan G., Williams A.D., and Chellgren B.W. Oligoproline effects on polyglutamine conformation and aggregation J. Mol. Biol. 355 2006 524 535 (Pubitemid 41785754)
26. Khare S.D., Ding F., Gwanmesia K.N., and Dokholyan N.V. Molecular origin of polyglutamine aggregation in neurodegenerative diseases PLoS Comput. Biol. 1 2005 230 235
27. Wang X., Vitalis A., Wyczalkowski M.A., and Pappu R.V. Characterizing the conformational ensemble of monomeric polyglutamine Proteins 63 2006 297 311
28. Leitgeb B., Kerenyi A., Bogar F., Paragi G., Penke B., and Rakhely G. Studying the structural properties of polyalanine and polyglutamine peptides J. Mol. Model. 13 2007 1141 1150
29. Vitalis A., Wang X., and Pappu R.V. Quantitative characterization of intrinsic disorder in polyglutamine: insights from analysis based on polymer theories Biophys. J. 93 2007 1923 1937 (Pubitemid 47437577)
30. Nakano M., Watanabe H., Rothstein S.M., and Tanaka S. Comparative characterization of short monomeric polyglutamine peptides by replica exchange molecular dynamics simulation J. Phys. Chem. B 114 2010 7056 7061
31. Lakhani V.V., Ding F., and Dokholyan N.V. Polyglutamine induced misfolding of huntingtin exon1 is modulated by the flanking sequences PLoS Comput. Biol. 6 2010 e1000772
32. Laghaei R., and Mousseau N. Spontaneous formation of polyglutamine nanotubes with molecular dynamics simulations J. Chem. Phys. 132 2010 8
33. Crick S.L., Jayaraman M., Frieden C., Wetzel R., and Pappu R.V. Fluorescence correlation spectroscopy shows that monomeric polyglutamine molecules form collapsed structures in aqueous solutions Proc. Natl Acad. Sci. USA 103 2006 16764 16769 (Pubitemid 44737327)
34. Walters R.H., and Murphy R.M. Examining polyglutamine peptide length: a connection between collapsed conformations and increased aggregation J. Mol. Biol. 393 2009 978 992
35. Dougan L., Li J.Y., Badilla C.L., Berne B.J., and Fernandez J.M. Single homopolypeptide chains collapse into mechanically rigid conformations Proc. Natl Acad. Sci. USA 106 2009 12605 12610
36. Starikov E.B., Lehrach H., and Wanker E.E. Folding of oligoglutamines: a theoretical approach based upon thermodynamics and molecular mechanics J. Biomol. Struct. Dyn. 17 1999 409 427 (Pubitemid 30036652)
37. Vitalis A., Wang X., and Pappu R.V. Atomistic simulations of the effects of polyglutamine chain length and solvent quality on conformational equilibria and spontaneous homodimerization J. Mol. Biol. 384 2008 279 297
38. Trottier Y., Lutz Y., Stevanin G., Imbert G., Devys D., Cancel G., and Saudou F. Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias Nature 378 1995 403 406
39. Bennett M.J., Huey-Tubman K.E., Herr A.B., West A.P., Ross S.A., and Bjorkman P.J. A linear lattice model for poly-glutamine in CAG expansion diseases Proc. Natl Acad. Sci. USA 99 2002 11634 11639 (Pubitemid 34994451)
40. Li P., Huey-Tubman K.E., Gao T., Li X., West A.P. Jr, Bennett M.J., and Bjorkman P.J. The structure of a polyQ-anti-polyQ complex reveals binding according to a linear lattice model Nat. Struct. Mol. Biol. 14 2007 381 387 (Pubitemid 46685884)
41. Miller J., Arrasate M., Brooks E., Libeu C.P., Legleiter J., and Hatters D. Identifying polyglutamine protein species in situ that best predict neurodegeneration Nat. Chem. Biol. 7 2011 925 934
42. Pejchal R., Gach J.S., Brunel F.M., Cardoso R.M., Stanfield R.L., and Dawson P.E. A conformational switch in human immunodeficiency virus gp41 revealed by the structures of overlapping epitopes recognized by neutralizing antibodies J.Virol. 83 2009 8451 8462
43. Dyson H.J., and Wright P.E. Coupling of folding and binding for unstructured proteins Curr. Opin. Struct. Biol. 12 2002 54 60 (Pubitemid 34142721)
44. Dyson H.J. Expanding the proteome: disordered and alternatively folded proteins Q.Rev. Biophys. 44 2011 467 518
45. Kar K., Jayaraman M., Sahoo B., Kodali R., and Wetzel R. Critical nucleus size for disease-related polyglutamine aggregation is repeat-length dependent Nat. Struct. Mol. Biol. 18 2011 328 336
46. Fiumara F., Fioriti L., Kandel E.R., and Hendrickson W.A. Essential role of coiled coils for aggregation and activity of Q/N-rich prions and polyQ proteins Cell 143 2010 1121 1135
47. Eliezer D. Biophysical characterization of intrinsically disordered proteins Curr. Opin. Struct. Biol. 19 2009 23 30
48. Palidwor G.A., Shcherbinin S., Huska M.R., Rasko T., Stelzl U., and Arumughan A. Detection of alpha-rod protein repeats using a neural network and application to huntingtin PLoS Comput. Biol. 5 2009 e1000304
49. Thakur A.K., Jayaraman M., Mishra R., Thakur M., Chellgren V.M., and Byeon I.J. Polyglutamine disruption of the huntingtin exon 1 N terminus triggers a complex aggregation mechanism Nat. Struct. Mol. Biol. 16 2009 380 389
50. Atwal R.S., Desmond C.R., Caron N., Maiuri T., Xia J.R., Sipione S., and Truant R. Kinase inhibitors modulate huntingtin cell localization and toxicity Nat. Chem. Biol. 7 2011 453 460
51. Jayaraman M., Kodali R., Sahoo B., Thakur A.K., Mayasundari A., and Mishra R. Slow amyloid nucleation via α-helix-rich oligomeric intermediates in short polyglutamine-containing huntingtin fragments J. Mol. Biol. 415 2012 881 899
52. Takahashi Y., Okamoto Y., Popiel H.A., Fujikake N., Toda T., Kinjo M., and Nagai Y. Detection of polyglutamine protein oligomers in cells by fluorescence correlation spectroscopy J. Biol. Chem. 282 2007 24039 24048 (Pubitemid 47328008)
53. Ossato G., Digman M.A., Aiken C., Lukacsovich T., Marsh J.L., and Gratton E. A two-step path to inclusion formation of huntingtin peptides revealed by number and brightness analysis Biophys. J. 98 2010 3078 3085
54. Steffan J.S., Agrawal N., Pallos J., Rockabrand E., Trotman L.C., and Slepko N. SUMO modification of Huntingtin and Huntington's disease pathology Science 304 2004 100 104 (Pubitemid 38451465)
55. Atwal R.S., Xia J., Pinchev D., Taylor J., Epand R.M., and Truant R. Huntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicity Hum. Mol. Genet. 16 2007 2600 2615 (Pubitemid 47617727)
56. Rockabrand E., Slepko N., Pantalone A., Nukala V.N., Kazantsev A., and Marsh J.L. The first 17 amino acids of Huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis Hum. Mol. Genet. 16 2007 61 77 (Pubitemid 46156597)
57. Angeli S., Shao J., and Diamond M.I. F-actin binding regions on the androgen receptor and huntingtin increase aggregation and alter aggregate characteristics PLoS One 5 2010 e9053
58. Thompson L.M., Aiken C.T., Kaltenbach L.S., Agrawal N., Illes K., and Khoshnan A. IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome J. Cell Biol. 187 2009 1083 1099
59. Gu X., Greiner E.R., Mishra R., Kodali R., Osmand A., and Finkbeiner S. Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice Neuron 64 2009 828 840
60. Kelley N.W., Huang X., Tam S., Spiess C., Frydman J., and Pande V.S. The predicted structure of the headpiece of the Huntingtin protein and its implications on Huntingtin aggregation J. Mol. Biol. 388 2009 919 927
61. Rossetti G., Cossio P., Laio A., and Carloni P. Conformations of the Huntingtin N-term in aqueous solution from atomistic simulations FEBS Lett. 585 2011 3086 3089
62. Williamson T.E., Vitalis A., Crick S.L., and Pappu R.V. Modulation of polyglutamine conformations and dimer formation by the N-terminus of huntingtin J. Mol. Biol. 396 2010 1295 1309
63. Dlugosz M., and Trylska J. Secondary structures of native and pathogenic huntingtin N-terminal fragments J. Phys. Chem. B 115 2011 11597 11608
64. Stott K., Blackburn J.M., Butler P.J., and Perutz M. Incorporation of glutamine repeats makes protein oligomerize: implications for neurodegenerative diseases Proc. Natl Acad. Sci. USA 92 1995 6509 6513
65. Chen Y.W., Stott K., and Perutz M.F. Crystal structure of a dimeric chymotrypsin inhibitor 2 mutant containing an inserted glutamine repeat Proc. Natl Acad. Sci. USA 96 1999 1257 1261 (Pubitemid 29098438)
66. Tanaka M., Morishima I., Akagi T., Hashikawa T., and Nukina N. Intra- and intermolecular beta-pleated sheet formation in glutamine-repeat inserted myoglobin as a model for polyglutamine diseases J. Biol. Chem. 276 2001 45470 45475
67. Robertson A.L., Horne J., Ellisdon A.M., Thomas B., Scanlon M.J., and Bottomley S.P. The structural impact of a polyglutamine tract is location-dependent Biophys. J. 95 2008 5922 5930
68. Tobelmann M.D., and Murphy R.M. Location trumps length: polyglutamine-mediated changes in folding and aggregation of a host protein Biophys. J. 100 2011 2773 2782
69. Nagai Y., Inui T., Popiel H.A., Fujikake N., Hasegawa K., and Urade Y. A toxic monomeric conformer of the polyglutamine protein Nat. Struct. Mol. Biol. 14 2007 332 340 (Pubitemid 46608340)
70. Lamb D.J., Puxeddu E., Malik N., Stenoien D.L., Nigam R., and Saleh G.Y. Molecular analysis of the androgen receptor in ten prostate cancer specimens obtained before and after androgen ablation J. Androl. 24 2003 215 225
71. Wang Q., Udayakumar T.S., Vasaitis T.S., Brodie A.M., and Fondell J.D. Mechanistic relationship between androgen receptor polyglutamine tract truncation and androgen-dependent transcriptional hyperactivity in prostate cancer cells J. Biol. Chem. 279 2004 17319 17328 (Pubitemid 38560492)
72. Cattaneo E., Rigamonti D., Goffredo D., Zuccato C., Squitieri F., and Sipione S. Loss of normal huntingtin function: new developments in Huntington's disease research Trends Neurosci. 24 2001 182 188 (Pubitemid 32166824)
73. Pearson C.E., and Sinden R.R. Trinucleotide repeat DNA structures: dynamic mutations from dynamic DNA Curr. Opin. Struct. Biol. 8 1998 321 330 (Pubitemid 28321359)
74. Perutz M.F., Johnson T., Suzuki M., and Finch J.T. Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases Proc. Natl Acad. Sci. USA 91 1994 5355 5358 (Pubitemid 24174325)
75. Thakur A., and Wetzel R. Mutational analysis of the structural organization of polyglutamine aggregates Proc. Natl Acad. Sci. USA 99 2002 17014 17019 (Pubitemid 36034090)
76. Bhattacharyya A.M., Thakur A.K., and Wetzel R. Polyglutamine aggregation nucleation: thermodynamics of a highly unfavorable protein folding reaction Proc. Natl Acad. Sci. USA 102 2005 15400 15405 (Pubitemid 41528069)
77. Slepko N., Bhattacharyya A.M., Jackson G.R., Steffan J.S., Marsh J.L., Thompson L.M., and Wetzel R. Normal-repeat-length polyglutamine peptides accelerate aggregation nucleation and cytotoxicity of expanded polyglutamine proteins Proc. Natl Acad. Sci. USA 103 2006 14367 14372 (Pubitemid 44484756)
78. Lee C.C., Walters R.H., and Murphy R.M. Reconsidering the mechanism of polyglutamine peptide aggregation Biochemistry 46 2007 12810 12820 (Pubitemid 350060102)
79. Jayaraman M., Kodali R., and Wetzel R. The impact of ataxin-1-like histidine insertions on polyglutamine aggregation Protein Eng. Des. Sel. 22 2009 469 478
80. Walters R.H., and Murphy R.M. Aggregation kinetics of interrupted polyglutamine peptides J.Mol. Biol. 412 2011 505 519
81. Sharma D., Sharma S., Pasha S., and Brahmachari S.K. Peptide models for inherited neurodegenerative disorders: conformation and aggregation properties of long polyglutamine peptides with and without interruptions FEBS Lett. 456 1999 181 185 (Pubitemid 29339065)
82. Chen S., Berthelier V., Hamilton J.B., O'Nuallain B., and Wetzel R. Amyloid-like features of polyglutamine aggregates and their assembly kinetics Biochemistry 41 2002 7391 7399 (Pubitemid 34602457)
83. Scherzinger E., Sittler A., Schweiger K., Heiser V., Lurz R., and Hasenbank R. Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology Proc. Natl Acad. Sci. USA 96 1999 4604 4609 (Pubitemid 29190383)
84. Morley J.F., Brignull H.R., Weyers J.J., and Morimoto R.I. The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans Proc. Natl Acad. Sci. USA 99 2002 10417 10422
85. McCampbell A., and Fischbeck K.H. Polyglutamine and CBP: fatal attraction? Nat. Med. 7 2001 528 530 (Pubitemid 32448308)
86. Ferrone F. Analysis of protein aggregation kinetics Methods Enzymol. 309 1999 256 274 (Pubitemid 29446454)
87. Smith M.H., Miles T.F., Sheehan M., Alfieri K.N., Kokona B., and Fairman R. Polyglutamine fibrils are formed using a simple designed beta-hairpin model Proteins 78 2010 1971 1979
88. VanSchouwen B.M., Oblinsky D.G., Gordon H.L., and Rothstein S.M. Structure propensities in mutated polyglutamine peptides Interdiscip. Sci. 3 2011 1 16
89. VanSchouwen B.M.B., Nakano M., Watanabe H., Tanaka S., Gordon H.L., and Rothstein S.M. Molecular mechanics and all-electron fragment molecular orbital calculations on mutated polyglutamine peptides J. Mol. Struct. Theochem. 944 2010 12 20
90. Esler W.P., Stimson E.R., Jennings J.M., Vinters H.V., Ghilardi J.R., and Lee J.P. Alzheimer's disease amyloid propagation by a template-dependent dock-lock mechanism Biochemistry 39 2000 6288 6295 (Pubitemid 30347132)
91. Pfeil W. The problem of the stability globular proteins Mol. Cell. Biochem. 40 1981 3 28
92. Marchut A.J., and Hall C.K. Effects of chain length on the aggregation of model polyglutamine peptides: molecular dynamics simulations Proteins 66 2007 96 109 (Pubitemid 44955982)
93. Demuro A., Mina E., Kayed R., Milton S.C., Parker I., and Glabe C.G. Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers J. Biol. Chem. 280 2005 17294 17300 (Pubitemid 41389198)
94. Legleiter J., Mitchell E., Lotz G.P., Sapp E., Ng C., and DiFiglia M. Mutant huntingtin fragments form oligomers in a polyglutamine length-dependent manner in vitro and in vivo J. Biol. Chem. 285 2010 14777 14790
95. Vitalis A., and Pappu R.V. Assessing the contribution of heterogeneous distributions of oligomers to aggregation mechanisms of polyglutamine peptides Biophys. Chem. 159 2011 14 23
96. Kodali R., and Wetzel R. Polymorphism in the intermediates and products of amyloid assembly Curr. Opin. Struct. Biol. 17 2007 48 57 (Pubitemid 46242190)
97. O'Nuallain B., Thakur A.K., Williams A.D., Bhattacharyya A.M., Chen S., Thiagarajan G., and Wetzel R. Kinetics and thermodynamics of amyloid assembly using a high-performance liquid chromatography-based sedimentation assay Methods Enzymol. 413 2006 34 74 (Pubitemid 44528684)
98. Sen S., Dash D., Pasha S., and Brahmachari S.K. Role of histidine interruption in mitigating the pathological effects of long polyglutamine stretches in SCA1: a molecular approach Protein Sci. 12 2003 953 962 (Pubitemid 36505430)
99. Thakur A.K., Yang W., and Wetzel R. Inhibition of polyglutamine aggregate cytotoxicity by a structure-based elongation inhibitor FASEB J. 18 2004 923 925
100. Popiel H.A., Nagai Y., Onodera O., Inui T., Fujikake N., and Urade Y. Disruption of the toxic conformation of the expanded polyglutamine stretch leads to suppression of aggregate formation and cytotoxicity Biochem. Biophys. Res. Commun. 317 2004 1200 1206 (Pubitemid 38496438)
101. Quan F., Janas J., and Popovich B.W. A novel CAG repeat configuration in the SCA1 gene: implications for the molecular diagnostics of spinocerebellar ataxia type 1 Hum. Mol. Genet. 4 1995 2411 2413
102. Arango M., Holbert S., Zala D., Brouillet E., Pearson J., and Regulier E. CA150 expression delays striatal cell death in overexpression and knock-in conditions for mutant huntingtin neurotoxicity J. Neurosci. 26 2006 4649 4659 (Pubitemid 44315366)
103. O'Nuallain B., Williams A.D., Westermark P., and Wetzel R. Seeding specificity in amyloid growth induced by heterologous fibrils J. Biol. Chem. 279 2004 17490 17499 (Pubitemid 38560512)
104. Scheuermann T., Schulz B., Blume A., Wahle E., Rudolph R., and Schwarz E. Trinucleotide expansions leading to an extended poly-l-alanine segment in the poly (A) binding protein PABPN1 cause fibril formation Protein Sci. 12 2003 2685 2692 (Pubitemid 37445094)
105. Scherzinger E., Lurz R., Turmaine M., Mangiarini L., Hollenbach B., and Hasenbank R. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo Cell 90 1997 549 558 (Pubitemid 27347244)
106. Ignatova Z., and Gierasch L.M. Extended polyglutamine tracts cause aggregation and structural perturbation of an adjacent beta barrel protein J. Biol. Chem. 281 2006 12959 12967 (Pubitemid 43855389)
107. Bulone D., Masino L., Thomas D.J., San Biagio P.L., and Pastore A. The interplay between polyQ and protein context delays aggregation by forming a reservoir of protofibrils PLoS ONE 1 2006 e111
108. Masino L., Nicastro G., Menon R.P., Dal Piaz F., Calder L., and Pastore A. Characterization of the structure and the amyloidogenic properties of the Josephin domain of the polyglutamine-containing protein ataxin-3 J. Mol. Biol. 344 2004 1021 1035 (Pubitemid 39491247)
109. Ellisdon A.M., Thomas B., and Bottomley S.P. The two-stage pathway of ataxin-3 fibrillogenesis involves a polyglutamine-independent step J. Biol. Chem. 281 2006 16888 16896
110. Bevivino A.E., and Loll P.J. An expanded glutamine repeat destabilizes native ataxin-3 structure and mediates formation of parallel beta-fibrils Proc. Natl Acad. Sci. USA 98 2001 11955 11960 (Pubitemid 32959808)
111. Chow M.K., Ellisdon A.M., Cabrita L.D., and Bottomley S.P. Polyglutamine expansion in ataxin-3 does not affect protein stability: implications for misfolding and disease J. Biol. Chem. 279 2004 47643 47651 (Pubitemid 39540910)
112. Chow M.K., Paulson H.L., and Bottomley S.P. Destabilization of a non-pathological variant of ataxin-3 results in fibrillogenesis via a partially folded intermediate: a model for misfolding in polyglutamine disease J. Mol. Biol. 335 2004 333 341 (Pubitemid 37494983)
113. Santambrogio C., Frana A.M., Natalello A., Papaleo E., Regonesi M.E., and Doglia S.M. The role of the central flexible region on the aggregation and conformational properties of human ataxin-3 FEBS J. 279 2012 451 463
114. Saunders H.M., Gilis D., Rooman M., Dehouck Y., Robertson A.L., and Bottomley S.P. Flanking domain stability modulates the aggregation kinetics of a polyglutamine disease protein Protein Sci. 20 2011 1675 1681
115. Masino L., Nicastro G., Calder L., Vendruscolo M., and Pastore A. Functional interactions as a survival strategy against abnormal aggregation FASEB J. 25 2011 45 54
116. Robertson A.L., Headey S.J., Saunders H.M., Ecroyd H., Scanlon M.J., Carver J.A., and Bottomley S.P. Small heat-shock proteins interact with a flanking domain to suppress polyglutamine aggregation Proc. Natl Acad. Sci. USA 107 2010 10424 10429
117. Walker F.O. Huntington's disease Lancet 369 2007 218 228 (Pubitemid 46107685)
118. Poirier M.A., Li H., Macosko J., Cai S., Amzel M., and Ross C.A. Huntingtin spheroids and protofibrils as precursors in polyglutamine fibrillization J. Biol. Chem. 277 2002 41032 41037 (Pubitemid 35215693)
119. Apostol B.L., Kazantsev A., Raffioni S., Illes K., Pallos J., and Bodai L. A cell-based assay for aggregation inhibitors as therapeutics of polyglutamine-repeat disease and validation in Drosophila Proc. Natl Acad. Sci. USA 100 2003 5950 5955 (Pubitemid 36576913)
120. Duennwald M.L., Jagadish S., Muchowski P.J., and Lindquist S. Flanking sequences profoundly alter polyglutamine toxicity in yeast Proc. Natl Acad. Sci. USA 103 2006 11045 11050 (Pubitemid 44148415)
121. II-like helix structure J. Mol. Biol. 374 2007 688 704 (Pubitemid 350027728)
122. II oligomers and the hydrophobic effect Biophys. J. 97 2009 2295 2305
123. Mishra R., Jayaraman M., Roland B.P., Landrum E., Fullam R., and Kodali R. Inhibiting nucleation of amyloid structure in a huntingtin fragment by targeting α-helix rich oligomeric intermediates J. Mol. Biol. 415 2012 900 917
124. Sivanandam V.N., Jayaraman M., Hoop C.L., Kodali R., Wetzel R., and van der Wel P.C. The aggregation-enhancing huntingtin N-terminus is helical in amyloid fibrils J. Am. Chem. Soc. 133 2011 4558 4566
125. Abedini A., and Raleigh D.P. A role for helical intermediates in amyloid formation by natively unfolded polypeptides? Phys. Biol. 6 2009 015005
126. Sathasivam K., Lane A., Legleiter J., Warley A., Woodman B., and Finkbeiner S. Identical oligomeric and fibrillar structures captured from the brains of R6/2 and knock-in mouse models of Huntington's disease Hum. Mol. Genet. 19 2010 65 78
127. Williams A.D., Portelius E., Kheterpal I., Guo J.T., Cook K.D., Xu Y., and Wetzel R. Mapping Abeta amyloid fibril secondary structure using scanning proline mutagenesis J. Mol. Biol. 335 2004 833 842 (Pubitemid 38352823)
128. Singer D., Zauner T., Genz M., Hoffmann R., and Zuchner T. Synthesis of pathological and nonpathological human exon 1 huntingtin J. Pept. Sci. 16 2010 358 363
129. Tam S., Spiess C., Auyeung W., Joachimiak L., Chen B., Poirier M.A., and Frydman J. The chaperonin TRiC blocks a huntingtin sequence element that promotes the conformational switch to aggregation Nat. Struct. Mol. Biol. 16 2009 1279 1285
130. Wacker J.L., Zareie M.H., Fong H., Sarikaya M., and Muchowski P.J. Hsp70 and Hsp40 attenuate formation of spherical and annular polyglutamine oligomers by partitioning monomer Nat. Struct. Mol. Biol. 11 2004 1215 1222
131. Broncel M., Falenski J.A., Wagner S.C., Hackenberger C.P., and Koksch B. How post-translational modifications influence amyloid formation: a systematic study of phosphorylation and glycosylation in model peptides Chemistry 16 2010 7881 7888
132. Nekooki-Machida Y., Kurosawa M., Nukina N., Ito K., Oda T., and Tanaka M. Distinct conformations of in vitro and in vivo amyloids of huntingtin-exon1 show different cytotoxicity Proc. Natl Acad. Sci. USA 106 2009 9679 9684
133. Serio T.R., Cashikar A.G., Kowal A.S., Sawicki G.J., Moslehi J.J., and Serpell L. Nucleated conformational conversion and the replication of conformational information by a prion determinant Science 289 2000 1317 1321 (Pubitemid 30656041)
134. Powers E.T., and Ferrone F. Kinetic models for protein misfolding and association C.M. Dobson, J.W. Kelly, M. Ramirez-Alvarado, Protein Misfolding Diseases: Current and Emerging Principles and Therapies 2009 Wiley New York, NY 73 92
135. Nagai Y., Tucker T., Ren H., Kenan D.J., Henderson B.S., and Keene J.D. Inhibition of polyglutamine protein aggregation and cell death by novel peptides identified by phage display screening J. Biol. Chem. 275 2000 10437 10442 (Pubitemid 30202104)
136. Tomita K., Popiel H.A., Nagai Y., Toda T., Yoshimitsu Y., and Ohno H. Structure-activity relationship study on polyglutamine binding peptide QBP1 Bioorg. Med. Chem. 17 2009 1259 1263
137. Hamuro L., Zhang G., Tucker T.J., Self C., Strittmatter W.J., and Burke J.R. Optimization of a polyglutamine aggregation inhibitor peptide (QBP1) using a thioflavin T fluorescence assay Assay Drug Dev. Technol. 5 2007 629 636
138. Popiel H.A., Nagai Y., Fujikake N., and Toda T. Protein transduction domain-mediated delivery of QBP1 suppresses polyglutamine-induced neurodegeneration in vivo Mol. Ther. 15 2007 303 309 (Pubitemid 46111880)
139. Nagai Y., Fujikake N., Ohno K., Higashiyama H., Popiel H.A., and Rahadian J. Prevention of polyglutamine oligomerization and neurodegeneration by the peptide inhibitor QBP1 in Drosophila Hum. Mol. Genet. 12 2003 1253 1259
140. Richardson J.S., and Richardson D.C. Principles and patterns of protein conformation G.D. Fasman, Prediction of Protein Structure and the Principles of Protein Conformation 1989 Plenum New York, NY 1 98
141. Lanning J.D., Hawk A.J., Derryberry J., and Meredith S.C. Chaperone-like N-methyl peptide inhibitors of polyglutamine aggregation Biochemistry 49 2010 7108 7118
142. Heiser V., Scherzinger E., Boeddrich A., Nordhoff E., Lurz R., and Schugardt N. Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: implications for Huntington's disease therapy Proc. Natl Acad. Sci. USA 97 2000 6739 6744 (Pubitemid 30412784)
143. Heiser V., Engemann S., Brocker W., Dunkel I., Boeddrich A., and Waelter S. Identification of benzothiazoles as potential polyglutamine aggregation inhibitors of Huntington's disease by using an automated filter retardation assay Proc. Natl Acad. Sci. USA 99 2002 16400 16406 (Pubitemid 35470985)
144. Ehrnhoefer D.E., Duennwald M., Markovic P., Wacker J.L., Engemann S., and Roark M. Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models Hum. Mol. Genet. 15 2006 2743 2751 (Pubitemid 44400401)
145. Ehrnhoefer D.E., Bieschke J., Boeddrich A., Herbst M., Masino L., and Lurz R. EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers Nat. Struct. Mol. Biol. 15 2008 558 566 (Pubitemid 351799141)
146. Hockly E., Tse J., Barker A.L., Moolman D.L., Beunard J.L., and Revington A.P. Evaluation of the benzothiazole aggregation inhibitors riluzole and PGL-135 as therapeutics for Huntington's disease Neurobiol. Dis. 21 2006 228 236 (Pubitemid 41817321)
147. Cao P., Meng F., Abedini A., and Raleigh D.P. The ability of rodent islet amyloid polypeptide to inhibit amyloid formation by human islet amyloid polypeptide has important implications for the mechanism of amyloid formation and the design of inhibitors Biochemistry 49 2010 872 881
148. Schiefner A., Chatwell L., Korner J., Neumaier I., Colby D.W., and Volkmer R. A disulfide-free single-domain V(L) intrabody with blocking activity towards huntingtin reveals a novel mode of epitope recognition J. Mol. Biol. 414 2011 337 355
149. Carmichael J., Chatellier J., Woolfson A., Milstein C., Fersht A.R., and Rubinsztein D.C. Bacterial and yeast chaperones reduce both aggregate formation and cell death in mammalian cell models of Huntington's disease Proc. Natl Acad. Sci. USA 97 2000 9701 9705 (Pubitemid 30650839)
150. Muchowski P.J., Schaffar G., Sittler A., Wanker E.E., Hayer-Hartl M.K., and Hartl F.U. Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils Proc. Natl Acad. Sci. USA 97 2000 7841 7846 (Pubitemid 30460735)
151. Hay D.G., Sathasivam K., Tobaben S., Stahl B., Marber M., and Mestril R. Progressive decrease in chaperone protein levels in a mouse model of Huntington's disease and induction of stress proteins as a therapeutic approach Hum. Mol. Genet. 13 2004 1389 1405 (Pubitemid 38961645)
152. Gutekunst C.A., Li S.H., Yi H., Mulroy J.S., Kuemmerle S., and Jones R. Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology J. Neurosci. 19 1999 2522 2534 (Pubitemid 29162401)
153. Li H., Li S.H., Cheng A.L., Mangiarini L., Bates G.P., and Li X.J. Ultrastructural localization and progressive formation of neuropil aggregates in Huntington's disease transgenic mice Hum. Mol. Genet. 8 1999 1227 1236 (Pubitemid 29328991)
154. Osmand A.P., Berthelier V., and Wetzel R. Imaging polyglutamine deposits in brain tissue Methods Enzymol. 412 2006 106 122 (Pubitemid 44548577)
155. Moulder K.L., Onodera O., Burke J.R., Strittmatter W.J., and Johnson E.M. Jr Generation of neuronal intranuclear inclusions by polyglutamine-GFP: analysis of inclusion clearance and toxicity as a function of polyglutamine length J. Neurosci. 19 1999 705 715 (Pubitemid 29036022)
156. Colby D.W., Cassady J.P., Lin G.C., Ingram V.M., and Wittrup K.D. Stochastic kinetics of intracellular huntingtin aggregate formation Nat. Chem. Biol. 2 2006 319 323 (Pubitemid 43787213)
157. Waelter S., Boeddrich A., Lurz R., Scherzinger E., Lueder G., Lehrach H., and Wanker E.E. Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation Mol. Biol. Cell. 12 2001 1393 1407 (Pubitemid 33044419)
158. Ross C.A., and Poirier M.A. Opinion: What is the role of protein aggregation in neurodegeneration? Nat. Rev. Mol. Cell Biol. 6 2005 891 898 (Pubitemid 41568738)
159. Olshina M.A., Angley L.M., Ramdzan Y.M., Tang J., Bailey M.F., Hill A.F., and Hatters D.M. Tracking mutant huntingtin aggregation kinetics in cells reveals three major populations that include an invariant oligomer pool J. Biol. Chem. 285 2010 21807 21816
160. Chai Y., Shao J., Miller V.M., Williams A., and Paulson H.L. Live-cell imaging reveals divergent intracellular dynamics of polyglutamine disease proteins and supports a sequestration model of pathogenesis Proc. Natl Acad. Sci. USA 99 2002 9310 9315 (Pubitemid 34764610)
161. Stenoien D.L., Mielke M., and Mancini M.A. Intranuclear ataxin1 inclusions contain both fast- and slow-exchanging components Nat. Cell Biol. 4 2002 806 810 (Pubitemid 35214775)
162. Lajoie P., and Snapp E.L. Formation and toxicity of soluble polyglutamine oligomers in living cells PLoS ONE 5 2010 e15245
163. Cummings C.J., Mancini M.A., Antalffy B., DeFranco D.B., Orr H.T., and Zoghbi H.Y. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1 Nat. Genet. 19 1998 148 154 (Pubitemid 28248795)
164. Nucifora F.C. Jr, Sasaki M., Peters M.F., Huang H., Cooper J.K., and Yamada M. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity Science 291 2001 2423 2428 (Pubitemid 32231807)
165. Jiang H., Nucifora F.C. Jr, Ross C.A., and DeFranco D.B. Cell death triggered by polyglutamine-expanded huntingtin in a neuronal cell line is associated with degradation of CREB-binding protein Hum. Mol. Genet. 12 2003 1 12 (Pubitemid 36097710)
166. Engelender S., Sharp A.H., Colomer V., Tokito M.K., Lanahan A., and Worley P. Huntingtin-associated protein 1 (HAP1) interacts with the p150Glued subunit of dynactin Hum. Mol. Genet. 6 1997 2205 2212 (Pubitemid 27501070)
167. Boutell J.M., Thomas P., Neal J.W., Weston V.J., Duce J., Harper P.S., and Jones A.L. Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin Hum. Mol. Genet. 8 1999 1647 1655 (Pubitemid 29423873)
168. Davranche A., Aviolat H., Zeder-Lutz G., Busso D., Altschuh D., Trottier Y., and Klein F.A.C. Huntingtin affinity for partners is not changed by polyglutamine length: aggregation itself triggers aberrant interactions Hum. Mol. Genet. 20 2011 2795 2806
169. Perutz M.F., Finch J.T., Berriman J., and Lesk A. Amyloid fibers are water-filled nanotubes Proc. Natl Acad. Sci. USA 99 2002 5591 5595 (Pubitemid 34411593)
170. Sharma D., Shinchuk L.M., Inouye H., Wetzel R., and Kirschner D.A. Polyglutamine homopolymers having 8-45 residues form slablike beta-crystallite assemblies Proteins 61 2005 398 411 (Pubitemid 41429147)
171. Sikorski P., and Atkins E. New model for crystalline polyglutamine assemblies and their connection with amyloid fibrils Biomacromolecules 6 2005 425 432 (Pubitemid 40277042)
172. Schneider R., Schumacher M.C., Mueller H., Nand D., Klaukien V., and Heise H. Structural characterization of polyglutamine fibrils by solid-state NMR spectroscopy J. Mol. Biol. 412 2011 121 136
173. Rossetti G., Magistrato A., Pastore A., Persichetti F., and Carloni P. Structural properties of polyglutamine aggregates investigated via molecular dynamics simulations J. Phys. Chem. B 112 2008 16843 16850
174. Ogawa H., Nakano M., Watanabe H., Starikov E.B., Rothstein S.M., and Tanaka S. Molecular dynamics simulation study on the structural stabilities of polyglutamine peptides Comput. Biol. Chem. 32 2008 102 110
175. Zhou Z.L., Zhao J.H., Liu H.L., Wu J.W., Liu K.T., and Chuang C.K. The possible structural models for polyglutamine aggregation: a molecular dynamics simulations study J. Biomol. Struct. Dyn. 28 2011 743 758
176. Kajava A.V., Baxa U., and Steven A.C. Beta arcades: recurring motifs in naturally occurring and disease-related amyloid fibrils FASEB J. 24 2010 1311 1319
177. Esposito L., Paladino A., Pedone C., and Vitagliano L. Insights into structure, stability, and toxicity of monomeric and aggregated polyglutamine models from molecular dynamics simulations Biophys. J. 94 2008 4031 4040
178. Zhang Q.C., Yeh T.L., Leyva A., Frank L.G., Miller J., and Kim Y.E. A compact beta model of huntingtin toxicity J. Biol. Chem. 286 2011 8188 8196
179. O'Nuallain B., Shivaprasad S., Kheterpal I., and Wetzel R. Thermodynamics of Abeta(1-40) amyloid fibril elongation Biochemistry 44 2005 12709 12718 (Pubitemid 41377310)
180. Lewandowski J.R., van der Wel P.C.A., Rigney M., Grigorieff N., and Griffin R.G. Structural complexity of a composite amyloid fibril J. Am. Chem. Soc. 133 2011 14686 14698
181. Nelson R., Sawaya M.R., Balbirnie M., Madsen A.O., Riekel C., Grothe R., and Eisenberg D. Structure of the cross-beta spine of amyloid-like fibrils Nature 435 2005 773 778 (Pubitemid 40839722)
182. Sawaya M.R., Sambashivan S., Nelson R., Ivanova M.I., Sievers S.A., and Apostol M.I. Atomic structures of amyloid cross-beta spines reveal varied steric zippers Nature 447 2007 453 457 (Pubitemid 46816731)
183. Berthelier V., Hamilton J.B., Chen S., and Wetzel R. A microtiter plate assay for polyglutamine aggregate extension Anal. Biochem. 295 2001 227 236 (Pubitemid 32756978)
184. Yang W., Dunlap J.R., Andrews R.B., and Wetzel R. Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells Hum. Mol. Genet. 11 2002 2905 2917
185. Ren P.H., Lauckner J.E., Kachirskaia I., Heuser J.E., Melki R., and Kopito R.R. Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates Nat. Cell Biol. 11 2009 219 U232
186. Franks F. Biophysics and Biochemistry at Low Temperatures 1985 Cambridge University Press Cambridge, UK
187. Franks F. Storage stabilization of proteins F. Franks, Protein Biotechnology: Isolation, Characterization and Stabilization 1993 Humana Press New York, NY 489 531
188. Chen S., and Wetzel R. Solubilization and disaggregation of polyglutamine peptides Protein Sci. 10 2001 887 891 (Pubitemid 32240515)
189. Jayaraman M., Thakur A.K., Kar K., Kodali R., and Wetzel R. Assays for studying nucleated aggregation of polyglutamine proteins Methods 53 2011 246 254
190. Padrick S.B., and Miranker A.D. Islet amyloid: phase partitioning and secondary nucleation are central to the mechanism of fibrillogenesis Biochemistry 41 2002 4694 4703 (Pubitemid 34275671)
191. Nichols M.R., Moss M.A., Reed D.K., Cratic-McDaniel S., Hoh J.H., and Rosenberry T.L. Amyloid-beta protofibrils differ from amyloid-beta aggregates induced in dilute hexafluoroisopropanol in stability and morphology J. Biol. Chem. 280 2005 2471 2480 (Pubitemid 40189347)
192. Sugase K., Dyson H.J., and Wright P.E. Mechanism of coupled folding and binding of an intrinsically disordered protein Nature 447 2007 1021 1025 (Pubitemid 46975749)